ImmunoCellular Therapeutics, Ltd. announced that on April 14, 2015, Richard Chin notified the Nominating and Corporate Governance Committee of the company that he will not stand for re-election as a director at the company's 2015 Annual Meeting of Stockholders. Dr. Chin will remain a director until the Annual Meeting and has no disagreements with the company relating to it's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.179 USD | -10.50% | -27.82% | -22.84% |
1st Jan change | Capi. | |
---|---|---|
-22.84% | 2.03Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+44.98% | 4.05TCr | |
-10.87% | 2.72TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- Richard Chin Not to Stand for Re-Election as Director of Immunocellular Therapeutics, Ltd